Finally, BC can be further divided into estrogen receptor‐positive, progesterone receptor‐positive, HER2‐positive, and TN BC based on the receptor status, which are proved to have different prognosis and responses to therapy [35, 36]. This evidence concerns the gene PGR and breast cancer.